Last reviewed · How we verify

NCT01622335

Effect OF Nitrous Oxide On Acute Pain and Opioid Consumption, and Chronic

Withdrawn NA Last updated 6 May 2024
What this trial tests

NA trial testing Nitrous oxide in Abdominal Hysterectomy (& Wertheim). Withdrawn.

Timeline
1 May 2012
Primary endpoint
1 December 2022
1 December 2023

Quick facts

Lead sponsorThe Cleveland Clinic
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Start date1 May 2012
Primary completion1 December 2022
Estimated completion1 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

The Cleveland Clinic

Who can join

Adults 18 to 65, female only, with Abdominal Hysterectomy (& Wertheim) or Nitrous Oxide. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The study is prospective and double blind. In the clinic, patients undergoing hysterectomy that meet the criteria for inclusion into the study and agreed to participate in the study will be randomized into two groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Nitrous oxide

Trials testing the same drug.

Other The Cleveland Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01622335.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing